2014-04-24 09:47:03 - Myanmar Pharmaceuticals and Healthcare Report Q3 2013 - a new market research report on companiesandmarkets.com
Despite its small size, Myanmar´s pharmaceutical market offers drugmakers strong revenueearning opportunities. Generic and over-the-counter drug companies in particular stand to benefit, as the population´s per capita expenditure on pharmaceuticals and healthcare remains low but set to rise.
However we believe that the country remains a high-risk market as a result of political risks arising from ethnic tensions, in addition to the challenging economic framework - the result of corruption and unclear regulations.
Headline Expenditure Projections
oPharmaceuticals: MMK241.2bn (US$280mn) in 2012 to MMK279.5bn (US$320mn) in 2013; +15.9% in local currency terms and 14.1% in US dollar terms.
oHealthcare: MMK992.5bn (US$1.1bn) in 2012 to MMK1,098.4bn (US$1.3bn) in 2013; +10.7% in local currency terms and +9.0% in US dollar terms.
report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.